
Hims & Hers Health, Inc. Class Action: The Gross Law Firm Reminds Hims & Hers Health, Inc. Investors Of The Pending Class Action Lawsuit With A Lead Plaintiff Deadline Of August 25, 2025 HIMS
Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
CLASS PERIOD: April 29, 2025 to June 23, 2025
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Hims was engaged in the“deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk;” (2) as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
DEADLINE: August 25, 2025 Shareholders should not delay in registering for this class action. Register your information here:
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HIMS during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 25, 2025. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: ...
Phone: (646) 453-8903


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Bitvault Raises $2M From GSR, Gemini, And Auros To Launch BTC-Backed Money
- NDAE Exchange Unveils NDAE Academy 2.0 For Crypto Learning Advancement
- Y4trade Announces Launch Of Proprietary Trading Platform With 200+ Fiat Withdrawal Options
- Strengthening UK Ties: Complycontrol Becomes Associate Member Of UK Finance
- Record Growth Fuels Next Phase For Revolving Games - Games Publishing, IP Deals & Player Expansion
- Cregis At Ifx Cyprus 2025: Presents Scalable Infrastructure For Forex Digital Transformation
Comments
No comment